spacer
The Healthcare Sales & Marketing Network celebrates 21 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Silence Therapeutics 

 HSMN NewsFeed - 18 Jul 2019
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part Of A Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
Biopharmaceuticals
 HSMN NewsFeed - 18 Jul 2019
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
Biopharmaceuticals Licensing
 HSMN NewsFeed - 25 Sep 2018
Dr. Dmitry Samarsky Joins Sirnaomics Senior Management Team as Chief Technology Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Dec 2017
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
Biopharmaceuticals Drug Delivery Ophthalmology Personnel
 HSMN NewsFeed - 13 Nov 2017
PlaqueTec Announces the Appointment of Annalisa Jenkins, MBBS, FRCP, as Chief Executive Officer
Devices Diagnostics Cardiology Personnel
 HSMN NewsFeed - 10 Feb 2012
Silence Therapeutics Announces Board Changes and Appointment of New Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Sep 2011
Silence Therapeutics Announces Appointment of Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Apr 2011
Portola Pharmaceuticals Appoints Dr. James Topper to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jun 2010
Quark Pharmaceuticals Closes $10 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Apr 2010
Silence Therapeutics Appoints Max Herrmann as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Feb 2010
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of Delayed Graft Function in Kidney Transplant Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Dec 2009
Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 23 Feb 2009
Flamel Technologies Announces Appointment of Jeffery S. Vick as Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel
Return to NewsFeed  
FindReps 2 - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps 2 - available on the Apple App Store for iPhone and iPad.